ICICI Prudential MF crosses 5% stake in Dr Reddy's Labs

Creeping acquisition near the thresholdOwnership Changes View source PDF Explain this filing

DRREDDY · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.6%Reaction day

₹1206.70

prior close

₹1198.40

announcement price

In-mkt

timing

Nifty 100market-0.2%-0.4% vs market

Pharmaceuticals peers, median of 166sector-0.4%-0.1% vs sector

On the reaction day the stock moved 0.4 pts less than Nifty 100 and 0.1 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.0

10m

-0.0

15m

-0.1

30m

-0.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.6-0.2-0.4-0.4-0.1

Next day

-1.2-0.4-0.8-0.3-0.9

-2.3-0.9-1.4-0.5-1.8

-3.0-1.3-1.8-1.3-1.7

-2.2-0.7-1.5-0.8-1.4

-2.7-0.7-2.0-0.4-2.3

-1.1-0.3-0.8-0.9-0.2

15d

-4.6-2.1-2.5+0.0-4.7

-5.1-5.4+0.3-0.1-5.0

+0.8-7.3+8.1-2.8+3.6

—————

UpDownMarket · Nifty 100Sector · Pharmaceuticals peers, median of 166Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

ICICI Prudential Mutual Fund bought 7,12,884 shares of Dr Reddy's Laboratories on Aug 12, 2026 via open market, raising its stake from 4.95% to 5.04%, crossing the 5% disclosure threshold. The fund clarified the holding is purely from an investment perspective and not for control.

Likely market impact

Strong institutional buying interest; crossing the 5% disclosure mark may boost investor confidence in the stock.